Medical device recalls Moderate risk

Diagnostica Stago, Inc. recalls STA - Fibrinogen 5. Model/Catalog Number: 00674. The STA - Fibrinogen 5 kit is intended for use with the analyzers of t…

Recall date
July 21, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2476-2025
FDA classification
Class II
Brand / firm
Diagnostica Stago, Inc.
Sold / distributed
Worldwide - US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, LA, MD, ME, MN, MO, MT, NC, OH, OK, OR, PA, PR, SD, VT, WI, WY and the countries of Algeria, Argentina, Austria, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, France, French Polynesie, Guadeloupe, India, Iran,…

Why it was recalled

Potential for contamination of STA-LIQUID ANTI-Xa by Stago Fibrinogen reagents in UFH and LMWH applications.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

STA - Fibrinogen 5. Model/Catalog Number: 00674. The STA - Fibrinogen 5 kit is intended for use with the analyzers of the STA-R, STA Compact and STA Satellite families for the quantitative determination of fibrinogen levels in human citrated plasma by the clotting method of Clauss.

Get recall alerts

Free email alert whenever Diagnostica Stago, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Diagnostica Stago, Inc.